NSE ScannerComparison · NSE · data 2026-10-31
Cohance Lifesciences Ltd vs OneSource Specialty Pharma Limited
In plain words
Size: OneSource Specialty Pharma Limited is about 1.1 times the market value of Cohance Lifesciences Ltd.
Return on equity: Cohance Lifesciences Ltd 6.4% vs OneSource Specialty Pharma Limited -1.3%.
Debt to equity: OneSource Specialty Pharma Limited 0.26 vs Cohance Lifesciences Ltd 0.1.
Differences in the numbers, not a recommendation of either stock.
Side by side
| COHANCE | ONESOURCE | |
|---|---|---|
| Price | ₹444.3 | ₹1,563 |
| Market cap | ₹17,005 cr | ₹17,926 cr |
| P/E | 161 | — |
| P/B | 4.4 | 3 |
| ROE | 6.4% | -1.3% |
| ROCE | 4.6% | -0.1% |
| Debt / equity | 0.1 | 0.26 |
| Operating margin | 5.8% | 6.4% |
| Dividend yield | 0.00% | 0.00% |
| Sales growth, 3 years (yearly) | 19.0% | 232.4% |
| Profit growth, 3 years (yearly) | -24.2% | — |
| 1-year return | -44.0% | -15.1% |
| Revenue, last 12 months | ₹2,142 cr | ₹1,684 cr |
| Net profit, last 12 months | ₹106 cr | ₹-2 cr |
| Latest quarter | — | Mar 2026 |
| Quarter net profit | — | ₹5 cr |
| Quarter profit vs a year earlier | — | — |
| Promoter holding | 57.48% | 30.47% |
| Health check | Weak (2.2/10) | Weak (3.5/10) |
Common questions
Which earns a higher return on equity?
Cohance Lifesciences Ltd (6.4% against -1.3%).
Which carries more debt?
OneSource Specialty Pharma Limited has the higher debt-to-equity ratio (0.26 against 0.1).